This finding has significant implications for genetic screening guidelines, including CDH1 testing for women with early-onset LBC or those with a family history of breast cancer, regardless of a HDGC history (Girardi et al. 2022). This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.